Target Name: MIR345
NCBI ID: G442910
Review Report on MIR345 Target / Biomarker Content of Review Report on MIR345 Target / Biomarker
MIR345
Other Name(s): microRNA 345 | MicroRNA 345 | MIRN345 | hsa-miR-345-5p | mir-345 | hsa-miR-345-3p | hsa-mir-345

MicroRNA 345: Regulation of Cellular Signaling Pathways, Cytoskeleton, Apoptosis and Inflammation

MicroRNA (miRNA) 345 is a non-coding RNA molecule that plays a critical role in various biological processes. It is made up of 204 amino acid residues and has a calculated molecular weight of 23.9 kilodaltons (KDa). MIR345 is a part of the 22 non-coding RNA genes known as microRNA genes (miRNA genes) that have been identified in the human genome.

MIR345 is a widely expressed gene and is expressed in various tissues and organs, including the brain, heart, liver, and muscle. It is also highly expressed in various diseases, including cancer, neurodegenerative diseases, and diseases associated with inflammation.

One of the unique features of MIR345 is its expression pattern. MIR345 is typically expressed in the cytoplasm of the cell and is mainly involved in the regulation of gene expression. It has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

MIR345 has also been shown to be involved in the regulation of cellular signaling pathways. For example, MIR345 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, a pathway that is involved in various cellular processes, including cell growth , survival, and angiogenesis.

In addition to its role in cellular signaling pathways, MIR345 has also been shown to be involved in the regulation of cellular cytoskeleton. It has been shown to play a role in the regulation of the actin filament, which is a protein that is involved in the structure and stability of the cytoskeleton.

MIR345 has also been shown to be involved in the regulation of cellular adhesion. It has been shown to play a role in the regulation of tight junction formation, a process that is involved in the regulation of the movement of substances into and out of cells.

In addition to its role in cellular signaling pathways and cytoskeleton regulation, MIR345 has also been shown to be involved in the regulation of cellular apoptosis. It has been shown to play a role in the regulation of apoptosis-related genes, including Bax and p53.

MIR345 has also been shown to be involved in the regulation of cellular inflammation. It has been shown to play a role in the regulation of various cytokines, including TNF-alpha and IL-12.

In addition to its role in cellular signaling pathways, cytoskeleton, and apoptosis regulation, MIR345 has also been shown to be involved in the regulation of cellular transport. It has been shown to play a role in the regulation of the transport of various molecules, including glucose and amino acids into and out of cells.

MIR345 has also been shown to be involved in the regulation of cellular signaling pathways related to cell adhesion. It has been shown to play a role in the regulation of the formation of tight junctions, which are specialized structures that allow substances to move into and out of cells.

MIR345 has also been shown to be involved in the regulation of cellular signaling pathways related to cell growth. It has been shown to play a role in the regulation of cell cycle progression, which is the process by which cells grow and divide.

In addition to its role in cell signaling pathways and cytoskeleton regulation, MIR345 has also been shown to be involved in the regulation of cellular stress responses. It has been shown to play a role in the regulation of cellular stress responses, including the regulation of cell survival and the response to

Protein Name: MicroRNA 345

The "MIR345 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR345 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667 | MIR3667HG | MIR3668 | MIR367 | MIR3670-1 | MIR3670-2 | MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2